These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1724957)

  • 21. Immunology. The Robin Hood of antigen presentation.
    De Libero G
    Science; 2004 Jan; 303(5657):485-7. PubMed ID: 14739449
    [No Abstract]   [Full Text] [Related]  

  • 22. [Specific and "half-specific" pathways of T-cell activation].
    Fleischer B
    Z Gastroenterol Verh; 1991 Mar; 26():312-3. PubMed ID: 1714195
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of antigen presenting cells in the immunogenicity of mycobacteria.
    Kamat RS
    Trop Med Parasitol; 1990 Sep; 41(3):326. PubMed ID: 2255854
    [No Abstract]   [Full Text] [Related]  

  • 24. The human T cell response to mitogenic microbial exotoxins.
    Fleischer B
    Curr Top Microbiol Immunol; 1991; 174():53-62. PubMed ID: 1802618
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of Dermatophagoides farinae-2-derived peptides and class II HLA molecules recognized by T cells from atopic individuals.
    Inoue R; Matsuoka T; Kondo N; Nishimura Y; Matsushita S
    Int Arch Allergy Immunol; 1997 Dec; 114(4):354-60. PubMed ID: 9414139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accessory cell-independent stimulation of human T cells by streptococcal M protein superantigen.
    Kotb M; Majumdar G; Tomai M; Beachey EH
    J Immunol; 1990 Sep; 145(5):1332-6. PubMed ID: 2143516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. At least five antigenic epitopes on the streptokinase molecule are recognized by human CD4+ TCR alpha beta+ T cells.
    Bruserud O; Elsayed S; Pawelec G
    Mol Immunol; 1992 Sep; 29(9):1097-104. PubMed ID: 1379678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells and epithelial expression of HLA class II determinants in relation to putative M cells of follicle-associated epithelium in human Peyer's patches.
    Bjerke K; Brandtzaeg P
    Adv Exp Med Biol; 1988; 237():695-8. PubMed ID: 2978207
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential antigen-processing pathways of the hepatitis B virus e and core proteins.
    Diepolder HM; Ries G; Jung MC; Schlicht HJ; Gerlach JT; Gr ner N; Caselmann WH; Pape GR
    Gastroenterology; 1999 Mar; 116(3):650-7. PubMed ID: 10029624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.
    Ruggiero G; Racioppi L; Manzo C; Pirozzi G; D'Oro U; Ferrone S; Zappacosta S; Fontana S
    Eur J Immunol; 1991 Jan; 21(1):29-33. PubMed ID: 1825060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of class I and II antigens in T cell recognition.
    Owen MJ; Crumpton MJ
    Br Med Bull; 1987 Jan; 43(1):228-40. PubMed ID: 3315099
    [No Abstract]   [Full Text] [Related]  

  • 32. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
    Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
    J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal sketches of the immune response.
    Lanzavecchia A
    EMBO J; 1988 Oct; 7(10):2945-51. PubMed ID: 3053159
    [No Abstract]   [Full Text] [Related]  

  • 34. Lectins and superantigens: membrane interactions of these compounds with T lymphocytes affect immune responses.
    Licastro F; Davis LJ; Morini MC
    Int J Biochem; 1993 Jun; 25(6):845-52. PubMed ID: 8344441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.
    Van Der Pouw Kraan TT; Stiekema FE; Teunissen MB; Bos JD; Kapsenberg L
    Immunology; 1989 Oct; 68(2):147-53. PubMed ID: 2572541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tweaking T cells with altered antigens.
    McCarthy M
    Lancet; 1996 Feb; 347(8999):460. PubMed ID: 8618493
    [No Abstract]   [Full Text] [Related]  

  • 37. Forced contact between antigen-presenting cells and T cells: consequences for T-cell activation.
    Höidén I; Clinchy B; Möller G
    Scand J Immunol; 1989 Oct; 30(4):481-7. PubMed ID: 2530625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.
    Cole BC; Kartchner DR; Wells DJ
    J Immunol; 1990 Jan; 144(2):425-31. PubMed ID: 2136890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
    Nishimura Y; Chen YZ; Kanai T; Yokomizo H; Matsuoka T; Matsushita S
    Intern Med; 1998 Oct; 37(10):804-17. PubMed ID: 9840700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging paradigms of T-cell co-stimulation.
    Kroczek RA; Mages HW; Hutloff A
    Curr Opin Immunol; 2004 Jun; 16(3):321-7. PubMed ID: 15134781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.